Alport syndrome is a collagen type IV disease caused by mutations in the COL4A5 gene with the X-linked form being most prevalent. The resultant a5(IV) collagen chain is a component of the glomerular and skin basement membranes (SBMs). Immunofluorescent determination of the a5(IV) chain in skin biopsies is the procedure of choice to identify patients. In 30% of patients, however, the mutant protein is still found in the SBM resulting in a normal staining pattern. In order to minimize or eliminate false results, we compared the distribution of the a2(IV) chain (another SBM component) and the a5(IV) chain by standard double label immunofluorescence (IF) and by confocal laser scanning microcopy. The study was performed on 55 skin biopsies of patients suspected of Alports and five normal control specimens. In normal skin, IF showed the classical linear pattern for both collagens along the basement membrane. Additionally, decreased a5(IV) was found in the bottom of the dermal papillary basement membrane. Confocal analysis confirmed the results and show a5(IV) focal interruptions. In suspected patients, both techniques showed the same rate of abnormal a5(IV) expression: segmental in women and absent in men. Our results show a physiological variation of a5(IV) location with focal interruptions and decreased expression in the bottom of the dermal basement membrane. Comparison of a5(IV) with a2(IV) expression is simple and eliminates technical artifacts.
Alport syndrome (AS) is a type IV collagen disease. 1 The X-linked form of the AS is the most prevalent transmission (85%), and is caused by mutations in COL4A5. 2 Approximately, 15% of AS are caused by COL4A3 and COL4A4 mutations with an autosomal recessive or rarely dominant pattern of inheritance. 1, 3, 4 The a1 chain of collagen IV (IV), a2(IV), a3(IV), a4(IV), and a5(IV) chains are components of glomerular basement membrane. 5 Skin basement membrane (SBM) is composed of a1(IV), a2(IV), a5(IV), and a6(IV), but not a3(IV) and a4(IV), rendering skin analysis uninformative in autosomal AS. In most X-linked AS patients, immunofluorescence (IF) analysis of the skin biopsy shows lack of a5(IV) chain, making skin biopsy a procedure of choice to identified X-linked AS patients. [6] [7] [8] [9] However, in 30-40% of patients with proven COL4A5 mutations, immunohistochemical staining for a5(IV) is normal, suggesting that the mutation had not prevented incorporation of the a5(IV) chain into glomerular and SBM. [10] [11] [12] [13] Recently, it was suggested that confocal laser staining microscopy (CLSM) skin analysis is more precise, allowing identification of an irregular distribution rather than the absence of the a5(IV) chain in male and female cases with COL4A5 mutations. 14 The aim of the study was to more precisely differentiate between physiological and abnormal distribution of a5(IV) chain in SBM of AS patients. For this purpose, we used dual staining for a2(IV), which is not affected in AS, and a5(IV). Furthermore, we studied all biopsies with standard and CLSM.
RESULTS
In normal skin, standard double direct IF showed an uninterrupted linear pattern of a2(IV) and a5(IV) along the SBM (Figure 1a-c) . Unexpectedly, we observed decreased or absence of a5(IV) expression in the bottom of dermal papillary BM, contrary to a2(IV), which was always strongly expressed (Figure 1d-f) .
CLSM gave the same results than standard IF (not shown). In addition, the high resolution image by CSLM revealed that a5(IV) could be focally absent in normal skin (two out of In male patients suspected of having X-linked AS, 11/20 biopsies (55%) showed a2 and a5(IV) normal expression with standard IF. Using CSLM, no defect potentially missed by double standard IF could be observed in these 11 patients. In nine cases, a5(IV) was totally absent (Figure 2a) , whereas, the a2(IV) staining was normal (Figure 2b) , with both methods.
Segmental a5(IV) distribution was never observed in any of the male patients, even with CLSM.
In female patients, 18/ 35 biopsies (51%) showed normal expression of both chains with standard IF. Again, CSLM did not identify abnormal staining in these18 female patients. Sixteen biopsies showed a segmental a5(IV) (Figure 2c and d) expression with a normal a2(IV) staining. Both standard IF and CSLM disclosed the same pattern.
In one case, a5(IV) was totally absent with normal a2(IV) distribution using both standard IF and CSLM.
In addition, among the 45 patients with continuous (11 male subjects) or mosaic (34 female subjects) positivity of a5(IV), CSLM revealed that in 7/45, a5(IV) was clearly absent in small foci (o5mm long) along the SBM, contrary to a2(IV), which was always strongly expressed. This pattern was similar to that observed in normal skin (cf above).
In two cases, direct comparison of a5(IV) with a2(IV) (inner control) revealed technical artifact. In those cases, the two chains were negative because of the absence of antibodies penetration on tissue sample (folds in the skin, Figure 3a When skin section was not perpendicular to SBM, we observed a coarsely granular distribution of a5(IV), which corresponds to a decreased signal with both methods (Figure 3h) . A similar decreased signal was observed with a2(IV) (Figure 3i) , excluding an abnormal expression of a5(IV).
DISCUSSION
It was recently described that CSLM analysis of skin biopsies could provide a more sensitive approach to diagnose AS when normal a5(IV) staining is observed by conventional IF, eliminating 'false-negative' results.
14 The aim of the study was to compare the two methods, but not to appreciate the impact of each method in term of sensibility and specificity. For this reason, we included all the biopsy received for 'suspected AS patients' and not only biopsy of patients with unequivocal clinical criteria of AS.
We applied standard IF and confocal analysis to double direct IF in skin biopsies with a solution containing antibodies against a5(IV) and a2(IV) chains (Figure 1) . The most important finding we observed with both methods was a decreased or a disappearance of a5(IV), but not a2(IV), along the bottom of dermal papillary BM in normal skin. This physiological variation of a5(IV) expression is described for the first time and could be related to local BM specialization, as it was suggested for hair growth cycle. 15 Thus, analysis of Alport female skin biopsies has to be interpreted with caution. Abnormal expression of a5(IV) can be ascertained only when the negative zone is distant from the bottom of dermal papillary BM and compared to a2(IV). In male patients, the expression of a5(IV) was normal or totally absent, and segmental expression was never found, even with CLSM.
In addition, we noted focal interruptions of a5(IV) (o5 mm long, quantified by the standard imaging analysis software of an LSM 510 system) in both several control and AS skin biopsies, without a2(IV) abnormality, excluding a technical artifact. We, thus, interpret this pattern as a physiological variation of a5(IV) distribution contrary to Muda et al.
14
Conventional double IF using combined a5(IV) and a2(IV) antibodies is fast and simple: (1) no antigen demasking by urea denaturation is needed, (2) only one section is necessary, (3) direct comparison of a5(IV) with a2(IV) (inner control) avoid misinterpretation related to technical artifact, (4) in our hands, CSLM results were identical to double IF and did not ascertain the existence of 'false-negative results' obtained with conventional IF.
In conclusion, skin biopsy is now the first choice in diagnosing AS. When excluding technical artefacts and physiological variations described herein, it is absolutely specific both for AS and for the X-linked mode of inheritance. However, it remains uninformative in a substantial proportion of patients when normal expression of a5(IV) is observed. Future developments in DNA analysis may circumvent these drawbacks. As skin expression of a5(IV) is one of the tools available for genetic counseling, misinterpretation could have disastrous consequences. The use of double standard IF described herein by trained observers should allow more confident interpretation in routine examination.
MATERIALS AND METHODS
We have studied all the skin biopsies addressed to the Department of Pathology during 1 year from 55 patients (35 women and 20 men) suspected of having X-linked AS, based on classical clinical criteria: family history of hematuria with or without progression to renal failure, progressive sensorineural hearing loss; biopsies from five patients investigated for systemic lupus erythematosus served as controls.
Immunohistochemical staining was performed on frozen sections (3 mm) with a commercially available combination of two monoclonal antibodies staining a5(IV) green (fluorescein isothiocyanate; H53 rat IgG2a/kappa and B51 rat IgG2a) and a2(IV) red (texas red; H25 rat IgG1/kappa) (Shigei medical Research Institute: CFT-45325).
The expression of the epidermal basement membrane a5(IV) chain was detected using a direct immunofluorescence method. The sections were air-dried for 30 min, incubated with monoclonal antibodies during 1 h.
The slides were examined with a LEICA DMLB 100 microscope equipped with epifluorescence illumination optics and then with an LSM Pascal confocal laser scanning microscope. The fluorescence intensity of the selected area was quantitatively analyzed using the standard imaging analysis software of an LSM 510 system. 
